Luye Pharma GroupFRA:LUP +5.88%47 Days Inventory is 148.35 as of Dec. 2025, which is 6% below its 10-year median of 157.02. GuruFocus rates FRA:LUP with a GF Score™ of 47/100 and a GF Value™ of €0.33 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 916 Drug Manufacturers companies, Luye Pharma Group ranks better than 54.69% on this metric.
The historical rank and industry rank for Luye Pharma Group's Days Inventory or its related term are showing as below:
FRA:LUP'
s Days Inventory Range Over the Past 10 Years
Min: 135.51 Med: 157.02 Max: 258.82
Current: 153.88
During the past 13 years, Luye Pharma Group's highest Days Inventory was 258.82. The lowest was 135.51. And the median was 157.02.
FRA:LUP's Days Inventory is ranked better than 54.69% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs FRA:LUP: 153.88
Luye Pharma Group's Days Inventory
declined
from Dec. 2024 (152.63) to Dec. 2025 (148.35).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Luye Pharma Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Luye Pharma Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.29.
Luye Pharma Group (FRA:LUP) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Luye Pharma Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Luye Pharma Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Luye Pharma Group Days Inventory Related Terms
Luye Pharma Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Luye Pharma Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Luye Pharma Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Luye Pharma Group Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Luye Pharma Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Luye Pharma Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Luye Pharma Group (FRA:LUP) has a Days Inventory of 148.35 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Luye Pharma Group and its competitors. This is near median its historical median of 157.02. Over the past decade, Luye Pharma Group's Days Inventory has ranged from 135.51 to 258.82. According to the industry distribution chart, Luye Pharma Group ranks #415 out of 916 companies in the Drug Manufacturers industry, placing it in the top 45.3%.
Is Luye Pharma Group's Days Inventory too high?
Luye Pharma Group's current Days Inventory of 148.35 is near median its 10-year median of 157.02. Over the past 10 years, this metric has ranged from a low of 135.51 to a high of 258.82. The Drug Manufacturers industry median Days Inventory is 164.43. Luye Pharma Group's value of 148.35 is 9.8% below this industry median. Based on the distribution chart, Luye Pharma Group ranks #415 out of 916 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Luye Pharma Group has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Luye Pharma Group's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Luye Pharma Group ranks #415 out of 916 companies for Days Inventory. This puts Luye Pharma Group in the upper half of its industry. The industry median Days Inventory is 164.43. Luye Pharma Group's value of 148.35 is 9.8% below this benchmark. Historically, Luye Pharma Group's own Days Inventory has ranged from 135.51 to 258.82 over the past decade. While the company's 10-year median is 157.02 vs. the industry median of 164.43, Luye Pharma Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Luye Pharma Group's current Days Inventory of 148.35 is 9.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Luye Pharma Group and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Luye Pharma Group's current Days Inventory is 148.35, which is near median its own 10-year median of 157.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Luye Pharma Group stock overvalued right now?
Based on GuruFocus' analysis, Luye Pharma Group (FRA:LUP) is currently considered Possible Value Trap. The stock's GF Value™ is €0.33, compared to a current price of €0.22 — trading 34.5% below its estimated fair value. The current Days Inventory is 148.35, which is near median its 10-year median of 157.02 and 9.8% below the Drug Manufacturers industry median of 164.43. Luye Pharma Group's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Luye Pharma Group (FRA:LUP), the current Days Inventory is 148.35 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Luye Pharma Group (FRA:LUP) Overvalued in 2026?
Based on GuruFocus' analysis, Luye Pharma Group stock appears to be undervalued.
The current stock price of €0.22 is trading 34.5% below its estimated GF Value™ of €0.33.
GuruFocus considers Luye Pharma Group to be Possible Value Trap.
Key valuation signals for FRA:LUP:
Days Inventory: 148.35 (near median its 10-year median of 157.02)
GF Value™: €0.33 vs. price of €0.22 (34.5% below fair value)
Industry Position: 9.8% below the Drug Manufacturers median (#415 of 916)
No single metric tells the full story. See the FRA:LUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on development, production, marketing and sale of pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company develops drugs for world-wide use in Asia, Europe, and the United States. The Group organizes its business segments by type of products. Oncology drugs, which derives maximum revenue; Cardiovascular system drugs; Alimentary tract and metabolism drugs; Central nervous system drugs; and others. Geographically, the group derives maximum revenue from Chinese Mainland, while it also has its presence in Asia (other than the Chinese mainland), European Union, and Other countries.
47GF Score
Get the complete analysis for FRA:LUP
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LUP has been successfully added to your 
